[Federal Register: May 27, 2009 (Volume 74, Number 100)]
[Notices]
[Page 25237-25239]
[DOCID:fr27my09-32]

-----------------------------------------------------------------------

ENVIRONMENTAL PROTECTION AGENCY

[EPA-HQ-OPP-2008-0560; FRL-8418-2]

Ethoprop; Notice of Receipt of Request to Voluntarily Amend a
Pesticide Registration to Terminate a Use

AGENCY: Environmental Protection Agency (EPA).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with section 6(f)(1) of the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA), as amended, EPA is issuing a
notice of receipt of a request by the registrant Bayer CropScience to
voluntarily amend a product registration to terminate use of ethoprop
in or on pineapple. EPA intends to grant this request at the close of
the comment period for this announcement unless the Agency receives
substantive comments within the comment period that would merit its
further review of the request, or unless the registrant withdraws their
request within this period. Upon acceptance of this request, any sale,
distribution, or use of products listed in this notice will be
permitted only if such sale, distribution, or use is consistent with
the terms as described in the final order.

DATES: Comments must be received on or before June 26, 2009.

ADDRESSES: Submit your comments, identified by docket identification
(ID) number EPA-HQ-OPP-2008-0560, by one of the following methods:
     Federal eRulemaking Portal: http://www.regulations.gov.
Follow the on-line instructions for submitting comments.
     Mail: Office of Pesticide Programs (OPP) Regulatory Public
Docket (7502P), Environmental Protection Agency, 1200 Pennsylvania
Ave., NW., Washington, DC 20460-0001.
     Delivery: OPP Regulatory Public Docket (7502P),
Environmental Protection Agency, Rm. S-4400, One Potomac Yard (South
Bldg.), 2777 S. Crystal Dr., Arlington, VA. Deliveries are only
accepted during the Docket Facility's normal hours of operation (8:30
a.m. to 4 p.m., Monday through Friday, excluding legal holidays).
Special arrangements should be made for deliveries of boxed
information. The Docket Facility telephone number is<PHONE_NUMBER>.
    Instructions: Direct your comments to docket ID number EPA-HQ-OPP-
2008-0560. EPA's policy is that all comments received will be included
in the docket without change and may be made available on-line at
http://www.regulations.gov, including any personal information
provided, unless the comment includes information claimed to be
Confidential Business Information (CBI) or other information whose
disclosure is restricted by statute. Do not submit information that you
consider to be CBI or otherwise protected through regulations.gov or e-
mail. The regulations.gov website is an ``anonymous access'' system,
which means EPA will not know your identity or contact information
unless you provide it in the body of your comment. If you send an e-
mail comment directly to EPA without going through regulations.gov,
your e-mail address will be automatically captured and included as part
of the comment that is placed in the docket and made available on the
Internet. If you submit an electronic comment, EPA recommends that you
include your name and other contact information in the body of your
comment and with any disk or CD-ROM you submit. If EPA cannot read your
comment due to technical difficulties

and cannot contact you for clarification, EPA may not be able to
consider your comment. Electronic files should avoid the use of special
characters, any form of encryption, and be free of any defects or
viruses.
    Docket: All documents in the docket are listed in the docket index
available at http://www.regulations.gov. Although listed in the index,
some information is not publicly available, e.g., CBI or other
information whose disclosure is restricted by statute. Certain other
material, such as copyrighted material, is not placed on the Internet
and will be publicly available only in hard copy form. Publicly
available docket materials are available either in the electronic
docket at http://www.regulations.gov, or, if only available in hard
copy, at the OPP Regulatory Public Docket in Rm. S-4400, One Potomac
Yard (South Bldg.), 2777 S. Crystal Dr., Arlington, VA. The hours of
operation of this Docket Facility are from 8:30 a.m. to 4 p.m., Monday
through Friday, excluding legal holidays. The Docket Facility telephone
number is<PHONE_NUMBER>.

FOR FURTHER INFORMATION CONTACT: Monica Wait, Special Review and
Reregistration Division (7508P), Office of Pesticide Programs,
Environmental Protection Agency, 1200 Pennsylvania Ave., NW.,
Washington, DC 20460-0001; telephone number:<PHONE_NUMBER>; fax
number:<PHONE_NUMBER>; e-mail address<EMAIL_ADDRESS>
SUPPLEMENTARY INFORMATION:

I. General Information

A. Does this Action Apply to Me?

    This action is directed to the public in general, and may be of
interest to a wide range of stakeholders including environmental, human
health, and agricultural advocates; the chemical industry; pesticide
users; and members of the public interested in the sale, distribution,
or use of pesticides. Since others also may be interested, the Agency
has not attempted to describe all the specific entities that may be
affected by this action. If you have any questions regarding the
applicability of this action to a particular entity, consult the person
listed under FOR FURTHER INFORMATION CONTACT.

B. What Should I Consider as I Prepare My Comments for EPA?

    1.  Submitting CBI. Do not submit this information to EPA through
regulations.gov or e-mail. Clearly mark the part or all of the
information that you claim to be CBI. For CBI information in a disk or
CD-ROM that you mail to EPA, mark the outside of the disk or CD-ROM as
CBI and then identify electronically within the disk or CD-ROM the
specific information that is claimed as CBI. In addition to one
complete version of the comment that includes information claimed as
CBI, a copy of the comment that does not contain the information
claimed as CBI must be submitted for inclusion in the public docket.
Information so marked will not be disclosed except in accordance with
procedures set forth in 40 CFR part 2.
    2. Tips for preparing your comments. When submitting comments,
remember to:
    i. Identify the document by docket ID number and other identifying
information (subject heading, Federal Register date and page number).
    ii. Follow directions. The Agency may ask you to respond to
specific questions or organize comments by referencing a Code of
Federal Regulations (CFR) part or section number.
    iii. Explain why you agree or disagree; suggest alternatives and
substitute language for your requested changes.
    iv. Describe any assumptions and provide any technical information
and/or data that you used.
    v. If you estimate potential costs or burdens, explain how you
arrived at your estimate in sufficient detail to allow for it to be
reproduced.
    vi. Provide specific examples to illustrate your concerns and
suggest alternatives.
    vii. Explain your views as clearly as possible, avoiding the use of
profanity or personal threats.
    viii. Make sure to submit your comments by the comment period
deadline identified.

II. Background on the Receipt of Request to Amend Registration to
Delete a Use

    This notice announces receipt by EPA of a request from registrant
Bayer CropScience to amend EPA Registration Number 264-599, Ethoprop
Technical, to terminate a use. In a letter dated April 23, 2009, Bayer
CropScience requested EPA to amend the Ethoprop Technical pesticide
product to terminate use in or on pineapple. There are no active
ethoprop end-use products registered for this use. Special Local Need
registration PR920002, the last remaining registration for use of
ethoprop on pineapple, was voluntarily cancelled by the registrant,
effective March 11, 2009. PR920002, for use in Puerto Rico only, was
linked to a Section 3 product that had also been voluntarily cancelled.
Since none of the three active ethoprop end-use products are registered
for use in or on pineapple, the Agency does not anticipate opposition
to terminating this use on the Ethoprop Technical product label.

III. What Action is the Agency Taking?

    This notice announces receipt by EPA of a request from Bayer
CropScience to amend an ethoprop product registration to terminate a
use. The affected product and the registrant making the request are
identified in Tables 1 and 2 of this unit.
    Under section 6(f)(1)(A) of FIFRA, registrants may request, at any
time, that their pesticide registrations be canceled or amended to
terminate one or more pesticide uses. Section 6(f)(1)(B) of FIFRA
requires that before acting on a request for voluntary cancellation,
EPA must provide a 30-day public comment period on the request for
voluntary cancellation or use termination. In addition, section
6(f)(1)(C) of FIFRA requires that EPA provide a 180-day comment period
on a request for voluntary cancellation or termination of any minor
agricultural use before granting the request, unless:
    1. The registrants request a waiver of the comment period, or
    2. The Administrator determines that continued use of the pesticide
would pose an unreasonable adverse effect on the environment.
    The ethoprop registrant has requested that EPA waive the 180-day
comment period. EPA will provide a 30-day comment period on the
proposed request.
    Unless a request is withdrawn by the registrant within 30 days of
publication of this notice, or if the Agency determines that there are
substantive comments that warrant further review of this request, an
order will be issued amending the affected registration.

    Table 1.--Ethoprop Product Registration with Pending Request for
                                Amendment
------------------------------------------------------------------------
                                                           Use Being
       Registration Number           Product Name         Terminated
------------------------------------------------------------------------
264-599                           Ethoprop Technical  Pineapple
------------------------------------------------------------------------

    Table 2 of this unit includes the name and address of record for
the registrant of the product listed in Table 1 of this unit.

           Table 2.--Registrant Requesting Voluntary Amendment
------------------------------------------------------------------------
            EPA Company Number                Company Name and  Address
------------------------------------------------------------------------
264                                         Bayer CropScience
                                            2 T.W. Alexander Drive
                                            Research Triangle Park, NC
                                             27709
------------------------------------------------------------------------

IV. What is the Agency's Authority for Taking this Action?

    Section 6(f)(1) of FIFRA provides that a registrant of a pesticide
product may at any time request that any of its pesticide registrations
be canceled or amended to terminate one or more uses. FIFRA further
provides that, before acting on the request, EPA must publish a notice
of receipt of any such request in the Federal Register. Thereafter,
following the public comment period, the Administrator may approve such
a request.

V. Procedures for Withdrawal of Request and Considerations for
Reregistration of Ethoprop

    Registrants who choose to withdraw a request for cancellation must
submit such withdrawal in writing to the person listed under FOR
FURTHER INFORMATION CONTACT, postmarked before June 26, 2009. This
written withdrawal of the request for cancellation will apply only to
the applicable FIFRA section 6(f)(1) request listed in this notice. If
the products has been subject to a previous cancellation action, the
effective date of cancellation and all other provisions of any earlier
cancellation action are controlling.

VI. Provisions for Disposition of Existing Stocks

    Existing stocks are those stocks of registered pesticide products
which are currently in the United States and which were packaged,
labeled, and released for shipment prior to the effective date of the
cancellation action.
    If the request for voluntary use termination is granted as
discussed in this unit, the Agency intends to issue a cancellation
order that will allow persons other than the registrant to continue to
sell and/or use existing stocks of canceled products until such stocks
are exhausted, provided that such use is consistent with the terms of
the previously approved labeling on, or that accompanied, the canceled
product. The order will specifically prohibit any use of existing
stocks that is not consistent with such previously approved labeling.
If, as the Agency currently intends, the final cancellation order
contains the existing stocks provision just described, the order will
be sent only to the affected registrants of the canceled products. If
the Agency determines that the final cancellation order should contain
existing stocks provisions different than the ones just described, the
Agency will publish the cancellation order in the Federal Register.

List of Subjects

    Environmental protection, Pesticides and pests.

    Dated: May 19, 2009.
 Richard P. Keigwin, Jr.,
Director, Special Review and Reregistration Division, Office of
Pesticide Programs.
[FR Doc. E9-12287 Filed 5-26-09; 8:45 am]

BILLING CODE 6560-50-S


[Federal Register: March 15, 2007 (Volume 72, Number 50)]
[Notices]
[Page 12240-12242]
[DOCID:fr15mr07-115]

-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[Release No. 34-55423; File No. SR-NYSEArca-2007-21]

Self-Regulatory Organizations; NYSE Arca, Inc.; Notice of Filing
and Immediate Effectiveness of Proposed Rule Change Relating to an
Exemption from Certain of the Exchange's Shareholder Approval
Requirements for Limited Partnerships

March 8, 2007.
    Pursuant to Section 19(b)(1) \1\ of the Securities Exchange Act of
1934 (the ``Act'') \2\ and Rule 19b-4 thereunder,\3\ notice is hereby
given that on February 23, 2007, NYSE Arca, Inc. (the ``Exchange''),
through its wholly owned subsidiary, NYSE Arca Equities, Inc. (``NYSE
Arca Equities''), filed with the Securities and Exchange Commission
(``Commission'') the proposed rule change as described in Items I and
II below, which Items have been substantially prepared by Exchange. The
Exchange has designated this proposal as non-controversial under
Section 19(b)(3)(A)(iii) of the Act \4\ and Rule 19b-4(f)(6)
thereunder,\5\ which renders the proposed rule change effective upon
filing with the Commission. The Commission is publishing this notice to
solicit comments on the proposed rule change from interested persons.
---------------------------------------------------------------------------

    \1\ 15 U.S.C.78s(b)(1).
    \2\ 15 U.S.C. 78a.
    \3\ 17 CFR 240.19b-4
    \4\ 15 U.S.C. 78s(b)(3)(A).
    \5\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

I. Self-Regulatory Organization's Statement of the Terms of Substance
of the Proposed Rule Change

    NYSE Arca is proposing to exempt limited partnerships (``LPs'')
from the obligations to obtain shareholder approval for the issuance of
common stock and related securities in the circumstances set forth in
subsections (8) through (11) of NYSE Arca Equities Rule 5.3(d). The
text of this proposed rule change is available on the Exchange's Web
site (http://www.nyse.com/RegulationFrameset.html? displayPage=http://www.nysearca.com/
 nysearca--reg/prf.asp), at the Exchange's Office of
's Office of

II. Self-Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

    In its filing with the Commission, the Exchange included statements
concerning the purpose of and basis for the proposed rule changes and
discussed any comments it received regarding the proposal. The text of
these statements may be examined at the places specified in Item IV
below. The Exchange has prepared summaries, set forth in sections A, B,
and C below, of the most significant aspects of such statements.

A. Self Regulatory Organization's Statement of the Purpose of, and
Statutory Basis for, the Proposed Rule Change

1. Purpose
    NYSE Arca is proposing to exempt limited partnerships (``LPs'')
from the obligations to obtain shareholder approval for the issuance of
common stock and related securities in the circumstances set forth in
subsections (8) through (11) of NYSE Arca Equities Rule 5.3(d).\6\ The
proposed amendment does not affect investors in any currently listed
company, as there are currently no LPs listed on the Exchange.
---------------------------------------------------------------------------

    \6\ This filing does not in any way limit the applicability of
the provisions of NYSE Arca Equities Rule 5.2(i) to limited
partnership rollups (as defined in Section 14(h) of the Securities
Exchange Act of 1934) or the continued applicability of any other
rule that is currently applicable to LPs.
---------------------------------------------------------------------------

    Subsections (8) through (11) of NYSE Arca Equities Rule 5.3(d)
require listed issuers to obtain shareholder approval prior to the
issuance of designated securities in the following situations:
     Issuances that will result in a change of control of the
issuer.
     In connection with the acquisition of the stock or assets
of another company, shareholder approval is needed in the following
circumstances:
     If any director, officer, or substantial shareholder of
the listed company has a 5% or greater interest (or such persons
collectively have a 10% or greater interest), directly or indirectly,
in the company or assets to be acquired or in the consideration to be
paid in the transaction (or series of related

transactions) and the present or potential issuance of common stock, or
securities convertible into or exercisable for common stock, could
result in an increase in outstanding common shares or voting power of
5% or more; or
     Where the present or potential issuance of common stock,
or securities convertible into or exercisable for common stock (other
than in a public offering for cash), could result in an increase in
outstanding common shares of 20% or more or could represent 20% or more
of the voting power outstanding before the issuance of such stock or
securities.
     In connection with a transaction other than a public
offering involving:
     The sale or issuance by the company of common stock (or
securities convertible into or exercisable for common stock) at a price
less than the greater of book or market value, which together with
sales by officers, directors or principal shareholders of the company
equals 20% or more of presently outstanding common stock, or 20% or
more of the presently outstanding voting power; or
     The sale or issuance by the company of common stock (or
securities convertible into or exercisable for common stock) equal to
20% or more of presently outstanding stock or voting power for less
than the greater of book or market value of the stock.
    The policy underlying these requirements is that shareholders
should have the right to vote on any issuance of common stock that is
materially dilutive of either their voting or economic interest in the
company. Nasdaq has essentially identical shareholder approval
requirements to those of the NYSE Arca. However, Nasdaq exempts LPs
from those requirements,\7\ which has placed NYSE Arca at a significant
disadvantage in competing with Nasdaq for initial public offerings and
transfers of LPs. To be treated as a partnership for federal tax
purposes, an LP must ensure that 90% of its income is derived from
``qualified sources,'' which generally refers only to income derived
from natural resource-related activities. Most listed LPs are engaged
in energy-related businesses. The typical business model of LPs in the
energy industry is to use their capital to acquire assets (e.g.,
pipelines) that produce predictable revenue streams and to commit in
their partnership agreements to distribute most of their profits to the
LP's unit holders. These LPs acquire assets frequently on an
opportunistic basis and pay for them by issuing additional LP units.
The ability of an LP listed on Nasdaq to issue additional LP units
without the expense and uncertainty of obtaining shareholder approval
provides Nasdaq with a significant advantage over NYSE Arca in
attracting and retaining listings of LPs.
---------------------------------------------------------------------------

    \7\ See Nasdaq Marketplace Rule 4360 (``Qualitative Listing
Requirements for Nasdaq Issuers That Are Limited Partnerships''),
which does not include the shareholder approval requirements found
in Nasdaq Marketplace Rule 4350 (``Qualitative Listing Requirements
for Nasdaq Issuers That Are Not Limited Partnerships''). See also
Exchange Act Release No. 30811 (June 15, 1992); 57 FR 28542 (June
25, 1992) (SR-NASD-91-58) (approving the NASD's adoption of non-
quantitative listing standards for partnerships, which did not
include shareholder approval requirements). See also Exchange Act
Release No. 34533 (August 15, 1994); 59 FR 43147 (August 22, 1994)
(SR-NASD-93-3) (approving the NASD's adoption of the predecessor
rule to Rule 4360, which also did not include shareholder approval
requirements for listed limited partnerships).
---------------------------------------------------------------------------

    The Exchange believes that an analysis of the policies regarding
voting and economic dilution underpinning its shareholder approval
requirements demonstrates that it is appropriate to exempt LPs from
their application. Listed LPs generally provide very limited voting
rights to their unit holders. Typically, control of the LP resides with
the general partner (``GP'') and the LP's board is that of the GP. The
owner of the GP appoints the board and the common unit holders of the
LP have no voting rights with respect to the election of directors. LP
partnership agreements generally provide that LP unit holders can vote
only on a merger or dissolution of the LP or on any amendment to the
partnership agreement that is adverse to their interests. As such,
investors who buy LP units have no expectation that they will be able
to vote and, therefore, the policy that shareholders should be able to
vote on any stock issuances that are materially dilutive of their
voting power is of less relevance to LPs than to regular corporations.
Furthermore, because LP unit holders generally do not have the right to
elect directors, most LPs do not hold annual meetings. Therefore, it
would not be possible for an LP to arrange for shareholder approval to
be obtained in conjunction with an annual meeting, as would be possible
for a regular company. Rather, an LP would have to call a special
meeting every time it needed approval of an issuance pursuant to the
shareholder approval rules.
    The Exchange also believes that the economic dilution concerns
underpinning the shareholder approval rules are also less relevant in
the case of LPs. Listed LPs typically are required under their
partnership agreements to distribute almost all of their earnings to
their unit holders and specify a minimum quarterly distribution that
the LP is required to make. As such, LPs will only invest in new assets
if they know that those assets will be sufficiently accretive to
earnings to pay the minimum quarterly distribution required for the
additional units that are sold to raise the capital to pay for those
assets. A failure to pay the minimum quarterly distribution, or a
reduction in the actual distribution level historically paid, would
likely, in the Exchange's view, have a negative effect on the trading
price of a listed LP, imposing a market discipline on management to
ensure that any additional issuances will not be economically dilutive.
2. Statutory Basis
    The proposed rule change is consistent with Section 6(b) \8\ of the
Act in general, and furthers the objectives of Section 6(b)(5) \9\ in
particular in that it is designed to prevent fraudulent and
manipulative acts and practices, to promote just and equitable
principles of trade, to foster cooperation and coordination with
persons engaged in facilitating transactions in securities, and to
remove impediments to and perfect the mechanisms of a free and open
market and a national market system. The Exchange believes that the
proposed rule change will increase competition among listing markets
and will remove a competitive disadvantage the Exchange currently has
vis a vis Nasdaq and is therefore designed to perfect the mechanism of
a free and open market.
---------------------------------------------------------------------------

    \8\ 15 U.S.C. 78f(b).
    \9\ 9 15 U.S.C. 78f(b)(5).
---------------------------------------------------------------------------

B. Self-Regulatory Organization's Statement on Burden on Competition

    The Exchange does not believe that the proposed rule change will
impose any burden on competition that is not necessary or appropriate
in furtherance of the purpose of the Act.

C. Self-Regulatory Organization's Statement on Comments on the Proposed
Rule Change Received From Members, Participants or Others

    Written comments on the proposed rule change were neither solicited
nor received.

III. Date of Effectiveness of the Proposed Rule Change and Timing for
Commission Action

    Because the proposed rule change does not: (1) Significantly affect
the protection of investors or the public interest; (2) impose any
significant burden on competition; and (3) become operative for 30 days
after the date of

the filing, or such shorter time as the Commission may designate if
consistent with the protection of investors and the public interest,
the proposed rule change has become effective pursuant to Section
19(b)(3)(A) of the Act \10\ and Rule 19b-4(f)(6) thereunder.\11\
---------------------------------------------------------------------------

    \10\ 15 U.S.C. 78s(b)(3)(A).
    \11\ 17 CFR 240.19b-4(f)(6).
---------------------------------------------------------------------------

    At any time within 60 days of the filing of the proposed rule
change, the Commission may summarily abrogate such rule change if it
appears to the Commission that such action is necessary or appropriate
in the public interest, for the protection of investors, or otherwise
in furtherance of the purposes of the Act.
    A proposed rule change normally may not become operative prior to
30 days after the date of filing.\12\ However, Rule 19b-4(f)(iii) \13\
permits the Commission to designate a shorter time if such action is
consistent with the protection of investors and the public interest.
The Exchange has requested that the Commission waive the 30-day
operative delay. The Commission believes that waiver of the 30 day
operative delay is consistent with the protection of investors and the
public interest.\14\ The Commission notes that because there are no LPs
presently listed on the NYSE Arca, there are no shareholders
retroactively or currently impacted by the proposed rule change.
Further, the proposed rule change will eliminate the competitive
disadvantage to the NYSE Arca resulting from the present disparity in
shareholder approval requirements between the NYSE Arca's and Nasdaq's
treatment of LPs, while still retaining for NYSE Arca-listed LPs the
provisions of the Exchange's rules relating to shareholder approval of
equity compensation plans.\15\
---------------------------------------------------------------------------

    \12\ 17 CFR 240.19b-4(f)(6)(iii). Rule 19b-4(f)(6)(iii) requires
hat a self-regulatory organization submit to the Commission written
notice of its intent to file the proposed rule change, along with a
brief description and text of the proposed rule change, at least
five business days prior to the date of filing of the proposed rule
change, or such shorter time as designated by the Commission. The
Exchange satisfied this requirement.
    \13\ 17 CFR 240.19b-4(f)(6)(iii).
    \14\ For purposes only of waiving the 30-day operative delay,
the Commission has considered the proposed rule's on efficiency,
competition, and capital formation. See 15 U.S.C. 78c(f).
    \15\ See NYSE Arca Rule 5.3(d)(1)-(7) (setting forth the
Exchange's rules with respect to shareholder approval of equity
compensation plans). The proposed rule change would only eliminate
the application of subparagraphs (8) through (11) to Rule 5.3(d) to
limited partnerships. The Commission believes that it is desirable
for the Exchange to have retained the requirements pertaining to
shareholder approval of equity compensation plans for NYSEArca-
listed limited partnerships.
---------------------------------------------------------------------------

IV. Solicitation of Comments

    Interested persons are invited to submit written data, views and
arguments concerning the foregoing, including whether the proposed rule
change, as amended, is consistent with the Act. Comments may be
submitted by any of the following methods:

Electronic Comments

     Use the Commission's Internet comment form (http://www.sec.gov/rules/sro.shtml.
); or     Send e-mail to<EMAIL_ADDRESS>Please include File

Number SR-NYSEArca-2007-21 on the subject line.

Paper Comments

     Send paper comments in triplicate to Nancy M. Morris,
Secretary, Securities and Exchange Commission, 100 F Street, NE.,
Washington, DC 20549-1090.

All submissions should refer to file Number SR-NYSEArca-2007-21. This
file number should be included on the subject line if e-mail is used.
To help the Commission process and review your comments more
efficiently, please use only one method. The Commission will post all
comments on the Commission's Internet Web site (http://www.sec.gov/rules/sro/shtml
). Copies of the submission, all subsequent amendments,

all written statements with respect to the proposed rule change that
are filed with the Commission, and all written communications relating
to the proposed rule change between the Commission and any person,
other than those that may be withheld from the public in accordance
with the provisions of 5 U.S.C. 552, will be available for inspection
and copying in the Commission's Public Reference Room. Copies of such
filings will also be available for inspection and copying at the
principal office of the Exchange. All comments received will be posted
without change; the Commission does not edit personal identifying
information from submissions. You should submit only information that
you wish to make available publicly. All submissions should refer to
File number SR-NYSEArca-2007-21 and should be submitted by April 5,
2007.

    For the Commission, by the Division of Market Regulation,
pursuant to delegated authority.\16\
---------------------------------------------------------------------------

    \16\ 17 CFR 200.30-3(a)(12).
---------------------------------------------------------------------------

Florence E. Harmon,
Deputy Secretary.
[FR Doc. E7-4692 Filed 3-14-07; 8:45 am]

BILLING CODE 8010-01-P


                            Panel Members for the
              Federal Insecticide, Fungicide, and Rodenticide Act
                       Scientific Advisory Panel Meeting
                          January 31-February 2, 2012

Scientific Issues Associated with Common Effects Methodology developed by the Office of Pesticide Programs and the Office of Water

Docket number:  EPA-HQ-OPP-2011-0898			OPP Docket Tel:<PHONE_NUMBER>

FIFRA SAP Chair

Kenneth M. Portier, Ph.D.
Program Director, Statistics
American Cancer Society
National Home Office
Atlanta, GA

FIFRA SAP Session Chair

Janice E. Chambers, Ph.D., DABT, ATS
William L. Giles Distinguished Professor
Director, Center for Environmental Health Sciences
College of Veterinary Medicine
Mississippi State University
Mississippi State, MS

Designated Federal Official

Sharlene R. Matten, Ph.D.
US Environmental Protection Agency
Office of Science Coordination & Policy
FIFRA Scientific Advisory Panel Staff
EPA East Building, MC 7201M
1200 Pennsylvania Avenue, NW
Washington, DC  20460
Tel:<PHONE_NUMBER>, Fax:<PHONE_NUMBER><EMAIL_ADDRESS>
FIFRA Scientific Advisory Panel Members

Stephen J. Klaine, Ph.D.
Professor and Director
Clemson University Institute of Environmental Toxicology
Department of Biological Sciences
Pendleton, SC

Martha S. Sandy, Ph.D.
Senior Toxicologist and Chief
Cancer Toxicology and Epidemiology Section
Reproductive and Cancer Hazard Assessment Branch
Office of Environmental Health Hazard Assessment
California Environmental Protection Agency
Oakland, CA

Daniel Schlenk, Ph.D.
Professor of Aquatic Ecotoxicology and Environmental Toxicology
Department of Environmental Sciences
University of California, Riverside
Riverside, CA

FQPA Science Review Board Members

Brian S. Anderson, M.A.
Research Specialist
Marine Pollution Studies Laboratory
University of California, Davis
Granite Canyon, CA

Bryan W. Brooks, Ph.D.
Professor and Director
Environmental Health Science Program
Environmental Science and Biomedical Studies
Center for Reservoir and Aquatic Systems Research
Baylor University
Waco, TX

G. Allen Burton, Jr., Ph.D.
Professor and Director
Cooperative Institute for Limnology and Ecosystems Research
Professor, School of Natural Resources and Environment &
Department of Geological Sciences
University of Michigan
Ann Arbor, MI

Peter M. Chapman, Ph.D., R.P.Bio.
Principal and Senior Environmental Scientist
Golder Associates Ltd.
Burnaby, BC, Canada

Mark T. D. Cronin, Ph.D.
Professor of Predictive Toxicology
School of Pharmacy and Biomolecular Sciences
Liverpool John Moores University
Liverpool, England

Nancy D. Denslow, Ph.D.
Professor
Department of Physiological Sciences
University of Florida
Gainesville, FL

Cheryl A. Murphy, Ph.D.
Assistant Professor
Department of Fisheries and Wildlife
Michigan State University
East Lansing, MI

James T. Oris, Ph.D.
Interim Associate Provost for Research and Scholarship &
Dean of the Graduate School
Professor of Zoology
Miami University
Oxford, OH

Geoffrey I. Scott, Ph.D.
Director
Charleston Center for Coastal Environmental Health and Biomolecular Research
National Oceanic & Atmospheric Administration, National Ocean Services
US Department of Commerce
Charleston, SC